OPTIMA: A Phase II Dose and Volume De-Escalation Trial for Human Papillomavirus-Positive Oropharyngeal Cancer
Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdz171
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2019
Authors
Publisher
Elsevier BV